Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600120166) titled 'Targeting TNF-a for inhibiting microglia-mediated glioma invasion and therapeutic strategy study' on March 10.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: The First Affiliated Hospital of the Army Medical University
Condition:
Glioblastoma
Intervention:
High TNF expression group:None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-03-10
Target Sample Size: High TNF expression group:68;Low TNF expression group:69;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=312526
Published by HT Digit...